Price alert —
Sign in to get a one-time email the moment ADVB crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · ADVB
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-12-31 | — | $0.0B | $-0.0B | $-0.0B | — | — |
| 2025-09-30 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-03-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2024-12-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare ADVB vs peers
Line ADVB up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with ADVB
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 0 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
No earnings history available.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| ADVB ★ | $0B | 1.3 | — | — | -1.7 | 0.8 | — | — | — | -102.14% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 20.2 | 4.0 | 18.8% | 2.0% | 0.7% | 4.57% |
| JNJ | $609B | 29.4 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 35.9 | 13.2 | 4.8 | 12.2 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.1 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.7 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.3 | 19.5 | 4.4 | 21.4 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 0.1%
| Holder | Shares | % out |
|---|---|---|
| Xtx Topco Ltd | 1,363 | 0.10% |
Insider activity · 90d
No insider trades for ADVB in last 90d.
Analyst estimates
yfinanceWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
Consensus: none (mean None). Distribution requires FINNHUB_API_KEY.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-07-17 | CURRENT REPORT | view · |
| 8-K | 2026-07-01 | CURRENT REPORT | view · |
| 8-K | 2026-06-30 | CURRENT REPORT | view · |
| DEF 14A | 2026-06-04 | DEFINITIVE PROXY STATEMENT | view · |
| 10-Q | 2026-05-15 | QUARTERLY REPORT | view · |
| 8-K | 2026-05-01 | CURRENT REPORT | view · |
| 8-K | 2026-04-14 | CURRENT REPORT | view · |
| 8-K | 2026-04-03 | CURRENT REPORT | view · |
| 8-K | 2026-03-30 | CURRENT REPORT | view · |
| 8-K | 2026-03-16 | CURRENT REPORT | view · |
| 8-K | 2026-02-26 | CURRENT REPORT | view · |
| 10-Q | 2026-02-13 | QUARTERLY REPORT | view · |
| 8-K | 2026-02-02 | CURRENT REPORT | view · |
| 8-K | 2026-01-27 | CURRENT REPORT | view · |
| 8-K | 2026-01-21 | CURRENT REPORT | view · |
| 8-K | 2025-12-30 | CURRENT REPORT | view · |
| 10-Q | 2025-11-19 | QUARTERLY REPORT | view · |
| 10-K | 2025-10-08 | ANNUAL REPORT | view · |
| 8-K | 2025-09-19 | CURRENT REPORT | view · |
| 8-K | 2025-07-24 | CURRENT REPORT | view · |
| S-1 | 2025-07-23 | REGISTRATION STATEMENT | view · |
| 8-K | 2025-06-06 | CURRENT REPORT | view · |
| 8-K | 2025-05-28 | CURRENT REPORT | view · |
| 10-Q | 2025-05-15 | QUARTERLY REPORT | view · |
| 10-Q | 2025-04-15 | QUARTERLY REPORT | view · |
| 8-K | 2025-03-10 | FORM 8-K | view · |
| S-1 | 2023-05-22 | FORM S-1 | view · |
About ADVB
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immun…
Options picks · ADVB
ITM + OTM ideas from the latest scanLoading…
Congress trades · ADVB
STOCK Act disclosuresLoading…
SEC filings & insiders · ADVB
EDGAR · liveLoading…
Holders · ADVB
Institutions & insider activityLoading…